The key secondary endpoints found the PsO pill to be beneficial in high-impact areas, including the scalp, palms, and soles.
Zasocitinib demonstrated high rates of psoriasis clearance for hard-to-treat areas and high-impact sites, Takeda announced in ...
Jul 16, 2026-- Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a nex ...
Takeda Pharmaceutical Co. Ltd. TAK on Friday revealed encouraging secondary data from two pivotal Phase 3 trials evaluating ...
The defence company won Large Employer Skills Champion and New Talent Inspiration Programme at the Enginuity Skills Awards ...
Cox’s Bazar is currently gripped by the panic of landslides. Amid the heavy rainfall of the past few days, at least two dozen ...
MCALESTER, Okla. — The final public hearing on Project Emerald June 22 was capped with a county commission vote to table creating two tax incentive districts for the hyperscale data center project.
The Inola City Council meeting drew a standing-room-only crowd Monday night as councilors considered whether to approve a moratorium on all construction within the city’s Industrial Heavy District, ...
Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results